Archive

Faceted archive

407 documents matching

February 2022
IN FORCE CDSCO · Public Notice · 2022-02-11
192 Rapid / CLIA / ELISA Kits approved for testing of Covid-19 as on 11.02.2022 2022-Feb-11 510 KB
CPC Diag. Pvt. Ltd.ImmunoshopIndia Pvt. Ltd.Athenese Dx Pvt. Ltd.
December 2021
IN FORCE CDSCO · Public Notice · 2021-12-10
195 Publice Notice dated 10.12.2021 2021-Dec-10 169 KB
IN FORCE CDSCO · Public Notice · 2021-12-09
196 PCR Kits approved for testing of Covid-19 as on 09.12.2021 2021-Dec-09 479 KB
Lab Genomics Co. Ltd.Life TechnologiesAthenese Dx Pvt. Ltd.
July 2021
IN FORCE Procedural & compliance ·? CDSCO · Circular · 2021-07-07
136 Circular regarding attending office regularly dated 07.07.2021 2021-Jul-07 602 KB
March 2020
IN FORCE Procedural & compliance ·? CDSCO · Circular · 2020-03-31
151 Circular regarding exemption of biometric machine attendance till 31.03.2020 2020-Mar-06 857 KB
September 2019
IN FORCE Procedural & compliance ·? CDSCO · Circular · 2019-09-09
161 Circular regarding WC dated 9.9.2019 2019-Sep-09 755 KB
April 2017
IN FORCE CDSCO · Circular · 2017-04-09
176 Merit List based on the written examination held on 09.04.2017 at NIB Noida for WHO Roational Fellowhip Selection 2017-Apr-10 3,500kb
August 2014
IN FORCE CDSCO · Circular · 2014-08-29
206 Postponement of the Seventh Expert Committee Meeting from 29.08.2014 to 05.09.2014 to examine the matters related to the approval of the safety and efficacy of Fixed Dose Combinations(FDC's) permi
Restech PharmaNOEL PharmaRexer Pharma
IN FORCE CDSCO · Circular · 2014-08-29
200 Seventh Meeting of the Expert Committee on 29.08.2014 to examine the matters related to the approval of the safety and efficacy of Fixed Dose Combinations(FDC's) permitted for manufacture for sale
Glenmark PharmaceuticalsSavi Pharrns Ltd.
IN FORCE CDSCO · Circular · 2014-08-27
205 Sixth Meeting of the Expert Committee on 27.08.2014 to examine the matters related to the approval of the safety and efficacy of Fixed Dose Combinations(FDC's) permitted for manufacture for sale i
Aurochem Laboratories (fF) Pvt. Ltd.Sun PharmaceuticalsGlenmark Pharmaceuticals
January 2013
IN FORCE Procedural & compliance ·? CDSCO · Public Notice · 2013-01-15
156 Clarification w.r.t. the new drug status of FDCs (Fixed Dose Combinations) which were scrutinized w.r.t. letter dated 15.1.2013 issued by this office and declared as rational 2023-Apr-05 22146 KB
Procedure to be followed for Subsequent applicant in respect of FDCs declared as rational by Prof. Kokate Committee and approved by DCG(I)-regarding.
Undated
IN FORCE CDSCO · Circular · undated
1 Inviting comments on consideration of the proposal regarding Issue of use of brand name extensions by the pharmaceutical firms 2026-Jul-06 53 KB
IN FORCE Import policy & restrictions ·? CDSCO · Circular · undated
145 Special Condition under which the permission for import of drug with residual shelf life less than 60% is allowed 2021-Apr-13 373 KB
IN FORCE CDSCO · Public Notice · undated
95 Inviting comments on standard IVD evaluation protocols drafted by ICMR and CDSCO 2025-Jan-02 2843 KB
IN FORCE Import policy & restrictions ·? CDSCO · Public Notice · undated
2 Sale of In-Vitro Fertilization media, reagents and related consumables used in Assisted Reproductive Technology procedures 2026-Jun-24 323 KB
Sale of In-Vitro Fertilization media, reagents and related consumables used in Assisted Reproductive Technology procedures
IN FORCE CDSCO · Circular · undated
1 Regulation of Formulation intermediates such as Directly Compressible granules, Taste masked granules, Modified release granules / Pellets 2026-Jun-24 758 KB
IN FORCE Import policy & restrictions ·? CDSCO · Circular · undated
2 Submission of Post Approval Changes Applications of Registration Certificate and Import Licence of Human Vaccines and Anti-sera through SUGAM Portal 2026-Jun-24 477 KB
IN FORCE CDSCO · Public Notice · undated
2 List of Suspended Ethics Committee by CLA 2026-Jun-12 1584 KB
IN FORCE CDSCO · Public Notice · undated
100 Approved panel of experts for the Subject Expert Committees 2024-Aug-29 493 KB
IN FORCE CDSCO · Public Notice · undated
196 Evaluation of certain pre 1988 permitted Fixed Dose Combinations (FDCs) de novo for manufacture for sale in the country without due approval from Central Licensing Authority 2021-Dec-28 123 KB
IN FORCE CDSCO · Public Notice · undated
1 List of Debarment of Principal Investigators by CLA 2026-Jun-12 2691 KB
para-2.4.2 Healthcare Global Enterprises
IN FORCE CDSCO · Circular · undated
1 Constitution of Consultancy Committee of Key Stakeholders for Advice on Suo-Motu Disclosure under Section 4 of the RTI Act, 2005 in CDSCO 2026-Jun-16 134 KB
IN FORCE CDSCO · Public Notice · undated
18 Testing Laboratories approved by Statas & UT in Form 37 of Drugs Rule 1945 and Cos 23 of Cosmetics Rule 2020 2026-Mar-10 455 KB
HS 88 Analys Lab Pvt. Ltd.Biocon Biosphere Ltd.Chalapathi institute of Pharmaceutical
IN FORCE CDSCO · Circular · undated
1 Submission of Compliance for lmported/manufactured Hair Color Cosmetics Products as per Cosmetics Rules, 2020 and applicable BIS Standards 2026-Jun-11 350 KB
IN FORCE Import policy & restrictions ·? CDSCO · Public Notice · undated
1 Prohibits to Import, manufacture, sale, distribution and use in any food producing animal rearing system of drug formulations containing 'Chloramphenicol or Nitrofurans drugs with immediate effect 2
Prohibits to Import, manufacture, sale, distribution and use in any food producing animal rearing system of drug formulations containing "Chloramphenicol! or Nitrofurans drugs with imediate effect.reg
IN FORCE Procedural & compliance ·? CDSCO · Circular · undated
1 Transfer List 2025 2026-Jun-03 653 KB
IN FORCE SEZ / EOU / FTWZ ·? CDSCO · Circular · undated
2 Implementation of Pharmacovigilance (PV) System as per the requirement of Schedule M of Drugs & Cosmetics Act 1940 and the Rules made there under 2026-Jun-03 316 KB
IN FORCE CDSCO · Public Notice · undated
194 Vigil on the activities of distribution & sale of suspected spurious Tocilizumab 400 mg/20 ml Injections in India 2021-Dec-28 404 KB
Vigil on the activities of distribution & sale of suspected spurious Tocilizumab 400mg/20mlI Injections in India
Roche Products (India) Pvt. Ltd.Cipla Ltd.
IN FORCE CDSCO · Public Notice · undated
174 Classification of Medical Device Pertaining to non-sterile, non-powered, hand-held or hand-manipulated Surgical Instruments for general use intended to be used in various general surgical procedur
IN FORCE Procedural & compliance ·? CDSCO · Public Notice · undated
84 Submission of clinical trial site addition and change of principal Investigator applications through sugam portal 2025-Feb-24 57 KB
Submission of Clinical Trial Site Addition and change of Principal Investigator applications through SUGAM portal
IN FORCE CDSCO · Public Notice · undated
173 Report of National List of Essential Medicines 2022 2022-Sep-13 8599 KB
IN FORCE CDSCO · Public Notice · undated
62 DCGI Public Hearing Form for applicants 2025-Jul-07 563 KB
IN FORCE CDSCO · Public Notice · undated
102 PRO feedback form Internal and Pro feedback form External 2024-Jul-26 909 KB
IN FORCE Import policy & restrictions ·? CDSCO · Public Notice · undated
190 Revised Schedule for Public hearing at PRO, CDSCO (HQ) 2022-Feb-22 386 KB
IN FORCE CDSCO · Public Notice · undated
158 Evaluation of 16 Fixed Dose Combinations (FDCs) by DTAB Sub-Committee which were earlier considered as irrational in the Expert Commiteee report of the Prof.Kokate Committee 2023-Mar-31 4207 KB
IN FORCE CDSCO · Public Notice · undated
200 Notice regarding Review of regulatory regime for drug approval 2021-Oct-14 348 KB
IN FORCE CDSCO · Public Notice · undated
172 National List of Essential Medicines 2022 2022-Sep-13 4579 KB
IN FORCE CDSCO · Public Notice · undated
166 Registration of Medical Device Testing Laboratory in Form MD-40 as per Medical Devices Rules (MDR) 2017 for Testing of Medical Devices on behalf of the manufacturer 2022-Dec-22 412 KB
IN FORCE CDSCO · Public Notice · undated
90 Grant of manufacturing licences for Large Volume Parenterals (Form 28D/Form 28DA) and endorsement of additional products in the licence through ONDLS portal 2025-Jan-07 138 KB
IN FORCE CDSCO · Public Notice · undated
129 Evaluation of certain pre 1988 permitted Fixed Dose Combinations FDCs de novo for manufacture for sale in the country without due approval from Central Licensing Authority 2024-Jan-11 2341 KB
Evaluation of certain pre 1988 permitted Fixed Dose Combinations (FDCs) de novo for manufacture for sale in the country without due approval from Central Licensing Authority -regarding.
IN FORCE Procedural & compliance ·? CDSCO · Public Notice · undated
188 Procedure to be followed for regularization of FDCs with respect to 294 FDCs examined' by the DTAB which were licensed to manufacture and market by State Licensing Authority without prior approval
Procedure to be followed for regularization of FDCs with respect to 294 FDCs examined: by the DTAB which were licensed to manufacture and market by State Licensing Authority without prior approval from DCG(I)regarding.
IN FORCE CDSCO · Public Notice · undated
146 Voluntary Recall of Digene Gel manufactured by M/s Abbott India Limited, L-18/19, Verna Industrial Estate, Salcette, Goa-403722 2023-Aug-31 1049 KB
Voluntary Recall of Digene Gel manufactured by M/s Abbott India Limited, L-18 /19, verna Industrial Estate, Salcette, Goa-403722 -reg.-
Abbott India Ltd.
IN FORCE CDSCO · Public Notice · undated
105 DTAB Sub-Committee to examine the proposal to regulate antibiotic and its irrational use date 16 may 2024 2024-May-16 447 KB
IN FORCE CDSCO · Public Notice · undated
7 Disposal/Rejection of Long Pending Applications on SUGAM Portal Awaiting Query Response 2026-May-04 779 KB
IN FORCE CDSCO · Public Notice · undated
17 Testing Laboratories approved by Statas&UT in Form 37 of Drugs Rule 1945 and Cos 23 of Cosmetics Rule 2020 2026-Mar-10 432 KB
HS 88 Analys Lab Pvt. Ltd.Biocon Biosphere Ltd.Chalapathi institute of Pharmaceutical
IN FORCE CDSCO · Public Notice · undated
91 Updation of exisiting risk based classification list_draft_dated 06 01 2025 for stakeholder comments 2025-Jan-06 3025 KB
IN FORCE Export policy & incentives ·? CDSCO · Public Notice · undated
150 Daily Updation of No.of Batches of Cough syrup sample for Export at Different Laboratories for testing Request not to submit any sample of cough syrup to CDTL Mumbai Lab 2023-Jun-21 1994 KB
IN FORCE Import policy & restrictions ·? CDSCO · Public Notice · undated
185 Special Condition under which the permission for import of drug with residual shelf life less than 60% is allowed 2022-May-06 78 KB
IN FORCE CDSCO · Public Notice · undated
32 List of Ethics Committees cancelled by CLA 2025-Dec-10 74 KB
IN FORCE Import policy & restrictions ·? CDSCO · Public Notice · undated
69 Cancellation of products under RC/COS-003211, for import of Cosmetics under Cosmetics Rules, 2020 2025-May-21 582 KB
Spectra Medical lndia Pvt. Ltd.
Page 2 / 9 ← Previous Next →